Understanding how a specific receptor affects cell signaling in diseases like cancer

Regulation of chemokine receptor signaling

NIH-funded research Medical College of Wisconsin · NIH-10912434

This study is looking at how a specific protein called CXCR4 works in our bodies, especially how it affects things like development, immune responses, and cancer, to help find better ways to treat diseases linked to this protein.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin NIH-funded
Lab location1 site (Milwaukee, United States)
Project IDNIH-10912434 on NIH RePORTER

What this research studies

This research investigates the mechanisms of G protein-coupled receptor (GPCR) signaling, focusing on the C-X-C chemokine receptor 4 (CXCR4), which plays a crucial role in various physiological processes and is linked to several diseases, including cancer. By using cell culture models and advanced imaging techniques, the study aims to uncover how CXCR4 signaling influences embryogenesis, immune function, and cancer progression. The research will explore the interactions of CXCR4 with other proteins and the biophysical factors that regulate its signaling pathways. This could lead to a better understanding of how to target CXCR4 in therapeutic settings.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with cancers that exhibit high levels of CXCR4 expression or those with conditions related to immune function and embryogenesis.

Not a fit: Patients with conditions unrelated to GPCR signaling or those not expressing CXCR4 may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating cancers associated with CXCR4 signaling.

How similar studies have performed: Previous research has shown promising results in targeting GPCR signaling pathways, indicating potential for success in this area.

Where this research is happening

Milwaukee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.